Fig. 4.
Correlation between level of minimal residual disease after consolidation and time to relapse.
Most patients with durable CR are in the group with less than 3.5 × 10−4 residual leukemic cells at the end of consolidation.
Correlation between level of minimal residual disease after consolidation and time to relapse.
Most patients with durable CR are in the group with less than 3.5 × 10−4 residual leukemic cells at the end of consolidation.
